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PERSPECTIVE
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The positive effects of exercise on health are supported by systematic reviews of longitudinal
studies and are widely accepted by clinicians [1]. In pregnancy, current advice from the United
Kingdom’s National Health Service (NHS) Choices and National Institute for Health and Care
Excellence, as well as the American College of Obstetricians and Gynecologists (ACOG), is
that exercise is more likely to be beneficial than harmful, with ACOG advising that “an exercise
programme [with] a goal of moderate intensity exercise for at least 20–30 minutes per day
should be developed with the patient” [2].
The research paper by Trine Moholdt and colleagues in PLOS Medicine describes a random-
ized trial on the effects of supervised exercise training in obese pregnant women [3]. Women
in the exercise group were offered exercise sessions supervised by a physical therapist at a hos-
pital three times weekly from baseline (12–18 weeks) until delivery. The sessions lasted 60 min-
utes and included 35 minutes of walking/jogging with additional resistance training. Women
were also advised to follow 50 minutes of a home exercise program at least once weekly. The
control group was offered routine care, which included “information about healthy eating and
a healthy lifestyle.”
Exercise training had no effect on the proportion of women reporting being physically
active each day in late pregnancy, with rates being just over 60% in both groups. Additionally,
the estimated energy expenditure during each session was low (around 400 kcal/session), and
only 50% of participants attended the equivalent of 50% of the sessions or more. However,
more women in the exercise intervention group reported exercise training in late pregnancy
(77% versus 23%).
There was no effect of the intervention on the preplanned primary outcome of mean weight
gain in the two groups: 10.5 kg (95% CI 8.9–12.0) for women in the exercise group and 9.2 kg
(6.8–11.6) for those in the control group. Nor did the intervention reduce the proportion of
women with weight gain above Institute of Medicine recommendations (5–9 kg for women
with a body mass index [BMI] 30 kg/m2). Amongst the secondary outcomes, a lower rate of
gestational diabetes mellitus (GDM) was reported in the exercise group: this apparent differ-
ence reached statistical significance for GDM diagnosed by WHO criteria (6.1% versus 27.3%)
but not by the International Association of Diabetes in Pregnancy Study Groups’ criteria.
These findings chime with a reduced risk of GDM reported for lifestyle interventions in high-
risk women with obesity or a previous history of GDM [4].
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The limitations of Moholdt and colleagues’ trial are the lower than planned sample size (91
rather than 150 women) and the inclusion of a small number of women (<10% overall) who
were overweight rather than obese. Nevertheless, these data complement those from a
Cochrane systematic review of diet or exercise interventions (or both) in pregnancy, which
demonstrated a small but significant reduction in the risk of excessive weight gain (relative risk
0.80 [95% CI 0.73–0.87]) but found no effect on mean weight gain in the majority of studies
[5].
What are the clinical implications of Moholdt and colleagues’ study? It is tempting to be
nihilistic and to point out that not only did the intervention fail to achieve its stated aim of
reducing mean weight gain but that it is likely to have been prohibitively expensive: provision
of three supervised exercise sessions per week for up to 30 weeks is a major financial undertak-
ing. A cost-effectiveness analysis was not performed as part of this study but is unlikely to
show benefit: during the time horizon of the study, even the reduction in GDM is unlikely to
offset the costs of the intervention.
So should we stop recommending exercise and/or stop testing exercise interventions in
obese pregnant women? The answer might be not that the intervention of exercise (supervised
or otherwise) is ineffective but that inappropriate outcomes are being used to assess utility in
pregnancy.
For the baby, maternal exercise in pregnancy, with or without a reduction in maternal
GDM, might minimize the adverse programming effects of maternal obesity on long-term
health of the offspring. We have shown that maternal obesity was associated with a 35%
increased risk of premature all-cause mortality on offspring by the age of 50 years—even a
modest reduction in this risk would have major health and economic benefits for society [6].
For the mother, exercise may not reduce mean weight gain in the index pregnancy, but if
the lifestyle change is maintained, it might mean that she enters the next pregnancy with a
lower BMI. Additionally, an exercise intervention may have benefits beyond the woman’s
childbearing years: a modest fall in bodyweight will reduce the lifelong risk of cardiovascular
disease [7,8].
In a separate research study also published in PLOS Medicine (the Mothers after Gestational
Diabetes in Australia [MAGDA] trial), Sharleen O'Reilly and colleagues focused on this lifelong
risk to the mother and evaluated a postnatal lifestyle intervention program in women diag-
nosed with GDM during pregnancy [9]. Five hundred and seventy-three women were
recruited, with half randomized to the intervention and the other half to usual care. The inter-
vention (diet and exercise advice) was delivered in a group exercise (five in total), together with
one individual session and two phone sessions, all over a period of 3 months. The majority of
the participants (66%) were overweight or obese.
As in the study by Moholdt and colleagues, engagement by participants was suboptimal in
O’Reilly and colleagues’ trial, with only 53% attending one or more sessions. According to the
trial’s coprimary endpoints, the intervention had no significant effect on fasting blood glucose,
although a small but significant difference in weight gain was observed over a 12-month period
(between-group difference of −0.95 kg, 95% CI −1.87 to −0.04), with the lower weight gain
recorded in the intervention group. As the authors mention, such an intense lifestyle interven-
tion may not be cost-effective compared with annual screening for diabetes with intervention
in those with impaired glucose tolerance. Additionally, both of these studies highlight the need
to engage patients in study design in order to optimize adherence to lifestyle interventions.
We note that Moholdt and colleagues plan to follow-up the mothers and babies recruited to
their study, to determine longer-term effects [10]. We would urge them and other investigators
conducting similar studies, including O’Reilly and colleagues, to do so. Given the major lifelong
adverse effects of maternal obesity for both the mother and the baby, effective therapeutic
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interventions are desperately needed [11]. Guidelines promoting exercise in pregnancy are
likely to do more good than harm, although they are not strongly supported by current evi-
dence. Metformin has been shown to be effective in reducing the risk of future diabetes in
women with a history of GDM, but lifestyle interventions are more effective in obese women
without a history of GDM [12]. Hence, lifestyle interventions offer the best promise for preven-
tion and should not be abandoned because of limited effectiveness or lack of effectiveness as
judged by short-term surrogate outcomes.
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